X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Piramal Healthcare with Divis Laboratories - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs DIVIS LABORATORIES - Comparison Results

PIRAMAL ENTERPRISES    Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PIRAMAL ENTERPRISES DIVIS LABORATORIES PIRAMAL ENTERPRISES/
DIVIS LABORATORIES
 
P/E (TTM) x 37.5 18.1 206.9% View Chart
P/BV x 3.7 3.9 95.2% View Chart
Dividend Yield % 0.7 1.6 41.2%  

Financials

 PIRAMAL ENTERPRISES   DIVIS LABORATORIES
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-16
DIVIS LABORATORIES
Mar-16
PIRAMAL ENTERPRISES/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,0652,484 42.9%   
Low Rs805918 87.7%   
Sales per share (Unadj.) Rs383.0142.3 269.3%  
Earnings per share (Unadj.) Rs55.141.9 131.5%  
Cash flow per share (Unadj.) Rs74.146.3 159.8%  
Dividends per share (Unadj.) Rs17.5010.00 175.0%  
Dividend yield (eoy) %1.90.6 318.3%  
Book value per share (Unadj.) Rs719.9161.5 445.7%  
Shares outstanding (eoy) m172.56265.47 65.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.412.0 20.4%   
Avg P/E ratio x17.040.6 41.8%  
P/CF ratio (eoy) x12.636.7 34.4%  
Price / Book Value ratio x1.310.5 12.3%  
Dividend payout %31.823.9 133.0%   
Avg Mkt Cap Rs m161,344451,525 35.7%   
No. of employees `0003.83.7 102.0%   
Total wages/salary Rs m16,8983,649 463.1%   
Avg. sales/employee Rs Th17,472.610,184.4 171.6%   
Avg. wages/employee Rs Th4,466.9984.1 453.9%   
Avg. net profit/employee Rs Th2,512.82,998.5 83.8%   
INCOME DATA
Net Sales Rs m66,09937,764 175.0%  
Other income Rs m2,425848 285.8%   
Total revenues Rs m68,52438,612 177.5%   
Gross profit Rs m18,72314,138 132.4%  
Depreciation Rs m3,2741,182 277.1%   
Interest Rs m9,38823 40,464.2%   
Profit before tax Rs m8,48513,781 61.6%   
Minority Interest Rs m30-   
Prior Period Items Rs m1,5930-   
Extraordinary Inc (Exp) Rs m4570-   
Tax Rs m1,0322,662 38.8%   
Profit after tax Rs m9,50611,119 85.5%  
Gross profit margin %28.337.4 75.7%  
Effective tax rate %12.219.3 62.9%   
Net profit margin %14.429.4 48.8%  
BALANCE SHEET DATA
Current assets Rs m47,48830,947 153.5%   
Current liabilities Rs m104,3625,195 2,008.9%   
Net working cap to sales %-86.068.2 -126.2%  
Current ratio x0.56.0 7.6%  
Inventory Days Days41117 34.8%  
Debtors Days Days5185 60.1%  
Net fixed assets Rs m26,53217,027 155.8%   
Share capital Rs m345531 65.0%   
"Free" reserves Rs m114,02442,341 269.3%   
Net worth Rs m124,22142,877 289.7%   
Long term debt Rs m75,8125 1,613,021.3%   
Total assets Rs m308,35649,684 620.6%  
Interest coverage x1.9595.0 0.3%   
Debt to equity ratio x0.60 556,761.8%  
Sales to assets ratio x0.20.8 28.2%   
Return on assets %6.122.4 27.3%  
Return on equity %7.725.9 29.5%  
Return on capital %10.032.2 30.9%  
Exports to sales %17.285.3 20.2%   
Imports to sales %6.622.9 28.8%   
Exports (fob) Rs m11,36232,198 35.3%   
Imports (cif) Rs m4,3648,654 50.4%   
Fx inflow Rs m14,43532,270 44.7%   
Fx outflow Rs m5,1838,775 59.1%   
Net fx Rs m9,25323,496 39.4%   
CASH FLOW
From Operations Rs m-67,77310,379 -653.0%  
From Investments Rs m-8,768-4,135 212.1%  
From Financial Activity Rs m76,199-6,241 -1,220.9%  
Net Cashflow Rs m-3423 -10,375.8%  

Share Holding

Indian Promoters % 52.9 52.0 101.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.0 11.8 33.9%  
FIIs % 26.6 19.0 140.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 16.5 17.2 95.9%  
Shareholders   93,274 31,796 293.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PIRAMAL ENTERPRISES With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  

Compare PIRAMAL ENTERPRISES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plummets 390 Points; Infosys Continues to Fall(01:30 pm)

After opening the day on a negative note, the share markets in India continued to witness selling pressure as Infosys cracked after Vishal Sikka's resignation as MD & CEO.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PIRAMAL ENTERPRISES SHARE PRICE


Aug 18, 2017 03:37 PM

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 5-YR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

MARKET STATS